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TO THE EDITOR
Hereditary palmoplantar keratoderma
(PPK) refers to a group of disorders
characterized by excessive epidermal
thickening of the palms and soles,
caused by mutations in several genes
(Kelsell and Stevens, 1999; Kimyai-
Asadi et al., 2002; Itin and Fistarol,
2005; Braun-Falco, 2009). Punctate PPK
is a relatively common entity (Itin and
Fistarol, 2005) characterized by numer-
ous punctate hyperkeratotic papules on
the palms and soles, occurring during
childhood or early adulthood (Buschke
and Fischer, 1910; Kimyai-Asadi et al.,
2002; Emmert et al., 2003a, b). Recently,
two back-to-back studies employed
linkage analyzes and exome sequenc-
ing to identify the gene responsible for
the punctate PPK linked to chromosome
15q22. In three large families, two distinct
heterozygous nonsense mutations in the
a- and g-adaptin binding gene (AAGAB),
coding for the AAGAB protein p34 were
disclosed (Giehl et al., 2012). Eight dif-
ferent nonsense, frame-shift, or splice-
site AAGAB mutations were identified in
18 further families (Pohler et al., 2012).
Here we report the clinical and mole-
cular characteristics of four patients
from three unrelated families with punc-
tate PPK, and analyze the consequences
of a heterozygous AAGAB splice-site
mutation in primary keratinocytes.
The 75-year-old patient 1 had par-
tially coalesced hyperkeratotic papules
on the palms and soles, more pro-
nounced on points of mechanical
pressure (Figure 1a). All nails were
thickened and dystrophic. Onset of the
skin lesions was in childhood and the
patient’s father, brother, and sons were
also affected. Hematoxylin and eosin
staining of a skin sample from the sole
revealed orthohyperkeratosis, areas of
columnar parakeratosis with reduced
granular layer, and perivascular, mostly
lymphocytic, infiltrates in the upper
dermis (not shown). The 48-year-old
patient 2 had punctate PPK, more pro-
minent on the soles since the age of 30
years (Figure 1b). The 50-year-old
patient 3 (Figure 1c) and the 46-year-
old patient 4, who are sisters, had first
symptoms in adolescence. Interestingly,
patient 4 reported that the lesions had
vanished during chemotherapy for breast
cancer, and reappeared gradually after
completion of the therapy (Figure 1d).
For mutation analysis, EDTA blood
was obtained from the patients follow-
ing written informed consent in adher-
ence to the Declaration of Helsinki
Principles and after approval by the
ethics committee of the University of
Freiburg. The primers for amplification
of AAGAB were designed with Primer 3
(http://frodo.wi.mit.edu/; Supplementary
Table S1 online). In all patients, hetero-
zygous AAGAB mutations were found:
c.870þ1G4A at the donor splice-site
of exon 9 in patient 1, c.21T4A, p.C7X
in patient 2 (Supplementary Figure S1
online), and c.481C4T, p.R161X in
patients 3 and 4. The mutation p.C7X
leading to a premature termination
codon in the N terminus of p34 has
not been reported previously (HGMD
Professional 2012.4). Two further unre-
lated patients with comparable clinical
phenotypes were analyzed for AAGAB
mutations; however, none were found.
So far, limited data on the role of p34
are derived from experiments with cell
lines (Giehl et al., 2012; Pohler et al.,
2012). We investigated the consequen-
ces of the AAGAB splice-site mutation
c.870þ1G4A in primary keratinocytes
from patient 1, which were isolated,
cultured (Konig and Bruckner-Tuderman,
1992), and compared with primary
normal human keratinocytes (NK).
Cells were lysed and subjected to
reverse transcripatase–PCR and immu-
noblotting (Pigors et al., 2011). In the
latter experiments, NK immortalized
with the HPV-E6E7 genes (designated
as NK-E6E7) were also included (a gift
from Dr Yannick Gache, Nice; Sprenger
et al., 2010).
Reverse transcripatase–PCR with
primers spanning exon 9 and comple-
mentary DNA from primary patient
keratinocytes and NK demonstrated
comparable single bands (Figure 2a).
The amplicons were cloned into theAccepted article preview online 5 April 2013; published online 16 May 2013
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TOPO-TA cloning vector (Invitrogen,
Darmstadt, Germany), plasmid DNA
was isolated from single clones and
sequenced with TA primers, revealing
in the patient two transcripts: the normal
allele and an aberrant transcript result-
ing from the out-of-frame insertion of
the first 17 nucleotides of intron 9
(Figure 2b). This led to a delayed termi-
nation codon. Immunoblot analysis (p34
polyclonal antibody, Sigma-Aldrich,
Hamburg, Germany) indicated that p34
protein levels were about 50% reduced
in the keratinocytes of patient 1 com-
pared with that in NK (Figure 2c), sug-
gesting that the mutation resulted in
degradation of the mutated polypeptide
rather than resulting in mRNA decay.
Notably, in contrast to primary NK
immortalized NK-E6E7 demonstrated
significantly lower levels of p34. As a
consequence of the mutation, immuno-
histochemical staining for the prolifera-
tion marker Ki-67 was significantly
enhanced in the affected skin of patient
1 (Figure 2d), indicating that the hyper-
keratosis is due to increased basal
keratinocyte proliferation. To analyze
whether the mechanism behind this is
dependent on the EGFR, as suggested
by a recent study (Pohler et al., 2012),
lysates of primary keratinocytes of
patient 1 and NK were subjected to
immunoblotting with antibodies to
EGFR (clone E30, DAKO, Bollschweil,
Germany), phosphorylated EGFR (P-Tyr
1092, indicating active signaling;
Abcam, Cambridge, UK), extracellular
signal–regulated kinase 1 or 2 (M5670,
Sigma-Aldrich), and diphosphorylated
extracellular signal–regulated kinase 1
or 2 (clone MAPK-YT, Sigma-Aldrich;
Figure 2e). These showed no significant
differences of the total and phosphory-
lated forms of EGFR and extracellular
signal–regulated kinase between pri-
mary patient keratinocytes and NK.
Interestingly, in immortalized NK-E6E7
low levels of p34 correlated with high
levels of EGFR.
The cytosolic protein with a Rab-like
GTPase domain, p34, was suggested
to function as a chaperone involved in
membrane trafficking (Page et al.,
1999). It interacts with AP1 and AP2,
proteins of the adaptor complexes of
clathrin-coated vesicles (Pohler et al.,
2012), having a role in protein sorting
between the Golgi network and the
endosomes, or at the plasma memb-
rane (Robinson and Bonifacino, 2001;
Robinson, 2004). In HaCaT cells
AAGAB siRNA–mediated knockdown
led to increased cell division, EGFR
expression, and phosphorylation (Pohler
et al., 2012). In this context it was
proposed that p34 is involved in
proliferation of basal keratinocytes by
controlling EGFR trafficking (Rappoport
and Simon, 2009; Pohler et al., 2012).
Although these mechanisms may
have a role, our findings suggest that
in primary keratinocytes from patients
with heterozygous AAGAB mutations
the presence of the wild-type allele
is sufficient to prevent EGFR over-
expression. Disease progression may
depend on the interplay with environ-
mental factors and additional regulatory
pathways.
Substantial phenotype variability
between the four patients was noted.
This is underscored by the fact that the
mutation p.R161X, which was asso-
ciated with a relatively mild phenotype
in patients 3 and 4 in the present study,
has previously been found in a young
individual with mild manifestations
(Pohler et al., 2012), but also in a
57-year-old individual with prono-
unced hyperkeratosis (Giehl et al.,
2012). Therefore, the disease severity
seems to progress with age, to be
dependent on the mechanical load on
the palms and soles, and individual
compliance to therapy. In the present
Patient 1 Patient 2 Patient 3 Patient 4
Figure 1. Clinical presentation of the patients. (a) Numerous hyperkeratotic plaques and papules on the right sole and palm of patient 1. (b) Hyperkeratotic
partially confluent papules on the sole and palm of patient 2. Panels (c) and (d) show punctate palmoplantar keratoderma (PPK) in patients 3 and 4, respectively.
Note that in all patients, hyperkeratosis prevails on pressure sites and on the soles. Small lesions are indicated by white arrows.
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study the observation that antiprolifera-
tive chemotherapeutic agents (taxanes,
anthracyclines) resulted in complete
remission of punctate keratoderma
supports hyperproliferation as a major
pathogenic mechanism and potential
therapeutic target.
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TO THE EDITOR
Atopic dermatitis (AD) is a common
chronic inflammatory skin disease.
The pathophysiological factors include
genetic predisposition to skin-barrier
defects, dysregulated immunity, and
hypersensitive allergen response
(Novak and Simon, 2011). The high
levels of proinflammatory cytokines in
AD initiate and maintain the inflam-
mation (Bieber, 2008) and mediate
cross-talk between innate and adaptive
immune systems. The recently described
cytosolic receptors of the nucleotide-
binding domain and leucine-rich
repeat (NLR)–containing family have
been shown to have a key role in
innate immune regulation. The NLR
family pyrin domain–containing pro-
teins (NLRPs) are recognized for forming
a multiprotein complex referred to as
the ‘‘inflammasome’’, which activates
the proinflammatory cytokines, interleu-
kin (IL)-1b, -18, and -33 (Li et al., 2008).
The above ILs are important in innate
immune functions and in the regulation
of adaptive immunity. Single-nucleotide
polymorphisms (SNPs) in NLRP1 have
been associated with vitiligo and related
autoimmune conditions (Jin et al.,
2007a,b), whereas SNPs in NLRP3
have been associated with food anaphy-
laxis and allergic asthma (Hitomi et al.,
2009), rheumatoid arthritis (Kastbom
et al., 2008), Crohn’s disease (Schoultz
et al., 2009; Villani et al., 2009), and
malignant melanoma (Verma et al.,
2012). As atopic manifestations, e.g.,
food allergies, asthma, allergic rhinitis,
and allergic conjunctivitis, are common,
we investigate the significance of seven
SNPs located in three different
inflammasome genes (NLRP1, NLRP3,
and CARD8) in the susceptibility of AD.
All of the studied SNPs except those
in NLRP1 are demonstrated to be of
functional significance.
A Swedish AD family material
(Bradley et al., 2000) including 1,708
individuals (1,260 affected) from 494
families with at least two affected
siblings were included in the analysis.
Measurements of total serum-IgE con-
centrations and IgE-specific antibodies
for food and inhalant allergens were
performed (Bradley et al., 2000). A
Swedish control population without
eczema comprising 732 healthy indivi-
duals was analyzed as the reference
population. We performed TaqMan
genotyping for variants of NLRP1
(rs6502867 and rs12150220), NLRP3
(rs35829419, rs10733113, rs10754558,
and rs4612666), and CARD8
(rs2043211) using an ABI Prism 7500
Sequence Detection System, with the
SDS 2.3 software for allelic discri-
mination (Applied Biosystems, Foster
City, CA). None of the SNPs were in
linkage disequilibrium (r2p0.3).
A pedigree disequilibrium test (PDT)
was carried out to investigate evidence
for the association between the genetic
variants and AD. Data for the family-
based association analysis, including
odds ratio (OR), 95% confidence
interval, and correction for multiple
testing (10.000 permutations), were cal-
culated using the UNPHASED program
(v.3.1.4, http://unphased.sourceforge.net).
All SNPs were shown to be in Hardy–
Weinberg equilibrium in the control
population. No statistical associations
between variants and AD were found
either overall or after stratification for
different phenotypes (Supplementary
Table S1a online). As gender-specific
associations have previously been
reported for NLRP3 SNPs (Schoultz
et al., 2009), we further stratified for
gender. The results showed a signifi-
cant association between NLRP3Accepted article preview online 5 April 2013; published online 16 May 2013
Abbreviations: AD, atopic dermatitis; CI, confidence interval; IL, interleukin; NLR, nucleotide-binding
domain and leucine-rich repeat; NLRP, NLR family pyrin domain–containing protein; OR, odds ratio; PDT,
pedigree disequilibrium test; SNP, single-nucleotide polymorphism
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